scholarly article | Q13442814 |
P50 | author | Shafaat Rabbani | Q77959450 |
P2093 | author name string | F Blasi | |
A Villa | |||
F Fazioli | |||
B Degryse | |||
M Resnati | |||
P433 | issue | 2 | |
P921 | main subject | chemotaxis | Q658145 |
P304 | page(s) | 649-662 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells | |
P478 | volume | 94 |
Q40355156 | An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. |
Q33722989 | Antibacterial mechanism of high-mobility group nucleosomal-binding domain 2 on the Gram-negative bacteria Escherichia coli |
Q81152153 | Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4) |
Q33384446 | Clathrin and LRP-1-independent constitutive endocytosis and recycling of uPAR. |
Q33709060 | Cleavage of the urokinase receptor (uPAR) on oral cancer cells: regulation by transforming growth factor - β1 (TGF-β1) and potential effects on migration and invasion. |
Q48220228 | D2A sequence of the urokinase receptor induces cell growth through αvβ3 integrin and EGFR. |
Q61799120 | Data on the inhibition of cell proliferation and invasion by the D2A-Ala peptide derived from the urokinase receptor |
Q43768136 | Data on the regulation of moesin and merlin by the urokinase receptor (uPAR): Model explaining distal activation of integrins by uPAR. |
Q37895294 | Development of novel therapeutics targeting the urokinase plasminogen activator receptor (uPAR) and their translation toward the clinic |
Q24545469 | EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury |
Q36112952 | Fibulin-5 binds urokinase-type plasminogen activator and mediates urokinase-stimulated β1-integrin-dependent cell migration. |
Q36302249 | Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator |
Q37216064 | LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies |
Q42505785 | Mice lacking tPA, uPA, or plasminogen genes showed delayed functional recovery after sciatic nerve crush. |
Q54960825 | Multifaceted Role of the Urokinase-Type Plasminogen Activator (uPA) and Its Receptor (uPAR): Diagnostic, Prognostic, and Therapeutic Applications. |
Q30361219 | Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell signaling. |
Q35136587 | Plasminogen activator promotes recovery following spinal cord injury |
Q35788649 | Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. |
Q41812511 | Rac mediates cytoskeletal rearrangements and increased cell motility induced by urokinase-type plasminogen activator receptor binding to vitronectin |
Q41976952 | Retinoic acid inhibits airway smooth muscle cell migration |
Q37570790 | Role of plasminogen activator in spinal cord remodeling after spinal cord injury |
Q74034559 | Searching for depolarization-induced genes that modulate synaptic plasticity and neurotrophin-induced genes that mediate neuronal differentiation |
Q35695503 | Serotonin induces pulmonary artery smooth muscle cell migration |
Q28570659 | The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells |
Q30499283 | The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. |
Q41713149 | The urokinase plasminogen activator receptor (UPAR) is preferentially induced by nerve growth factor in PC12 pheochromocytoma cells and is required for NGF-driven differentiation. |
Q33948206 | Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. |
Q43000092 | Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. |
Search more.